Skip to main content
. 2016 Dec 1;475(4):1252–1261. doi: 10.1007/s11999-016-5187-3

Table 1.

Categorical variables contained in the training and validation sets

Feature Training set (n = 189) Validation set (n = 815) p Value
Number of patients Percent Number of patients Percent Percent missing
Gender
 Male 85 45 369 45 0 0.91
 Female 104 55 446 55
Diagnosis group
 1.0 52 27 173 21 < 1 < 0.001*
 2.0 34 18 74 9
 3.0 103 55 567 70
Visceral metastases
 Yes 114 60 325 40 6 < 0.001*
 No 75 40 441 54
Lymph node metastases
 Yes 36 19 169 21 62 < 0.001*
 No 153 81 143 18
Number of bone metastases
 Solitary 55 29 123 15 3 < 0.001*
 Multiple 134 71 666 82
Pathologic fracture
 Complete 84 44 614 75 < 1 < 0.001*
 Impending 105 56 196 24
ECOG performance status
 0, 1, or 2 93 49 558 68 0 < 0.001*
 3 or 4 96 51 257 32
Survival > 1 months
 Yes 173 92 622 87 0 < 0.001*
 No 16 8 193 13
Survival > 6 months
 Yes 111 59 372 46 0 0.001*
 No 78 41 443 54

*Distributions are significantly different between the training and validation sets by the chi square method; Percent missing = the proportion of unknown or missing data in the validation set; ECOG = Eastern Cooperative Oncology Group.